Why Partner?
Partner with the Tumour Models Summit Nordics in 2026
The field of oncology modelling is transforming rapidly. With the FDA Modernization Act enabling the use of more sophisticated, patient-derived models and a global push toward precision oncology, the demand for advanced tumour models is accelerating. The Nordic region is emerging as a hub for innovation, driven by the need to replicate the complexities of the tumour microenvironment more effectively.
The Tumour Models Summit Nordics, confirmed to be returning in 2026, could be your gateway to this thriving market. The 2025 summit provided the space to connect with 70+ senior decision-makers from Sweden, Norway, Denmark, and Finland, and allowed attendees to position their brand as a leader in cutting-edge oncology solutions. This exclusive event offered unparalleled opportunities; partner with us in 2026 to showcase your expertise, forge strategic partnerships, and expand your market presence.
Why Partner with Us?
The 2025 summit provided a highly targeted platform to:
Showcase Your Expertise
Build Strategic Partnerships
Expand Your Market Presence
2025 Partners Demonstrated their capabilities in:
- In vivo and in vitro modelling
- Advanced imaging technologies
- Translational biomarker solutions
Leading the conversation on driving precision oncology forward.
Attendees engaged directly with senior decision-makers from pharma, biotech, and academia. Meet professionals actively seeking innovative tools and technologies to advance preclinical and translational oncology.
Attendees had the opportunity to establish their brand in the Nordic biotech ecosystem - a rapidly growing hub for precision oncology and next-generation tumour modelling.
